Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1993-02-26
1997-02-18
Wong, Leslie
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 32, 435 35, 435 39, 435968, 436172, C12Q 102
Patent
active
056041128
ABSTRACT:
The present invention provides methods of testing the cardiotoxicity of compounds and kits useful for the same.
REFERENCES:
Morrison and Boyd "Organic Chemistry," 3rd Edition 1975 pp. 1059-1062.
Orlandi, et al. JACC 19: Abstract No. 249 A. 1992.
Nadakavukaren, et al. Cancer Research vol. 45 pp. 6093-6099 1985.
Savi, et al. Eur. J. Nucl. Med. 15:597-600 (1989).
Bachur et al., "NADPH Cytochrome P-450 Reductase Activation of Quinone Anticancer Agents to Free Radicals", Proc. Natl. Acad. Sci. U.S.A., 76: 954-957 (1979).
Carvalho et al., "Subcellular Distribution and Analysis of Technetium-99m-MIBI in Isolated Perfused Rat Hearts", J. Nucl. Med. 33: 1516-1521 (1992).
Chen, "Mitochondrial Membrane Potential in Living Cells", Ann. Rev. Cell. Biol. 4: 155-181 (1988).
Crane et al., "Calcium Causes Release of Tc-99m-Sestamibi from Cardiac Mitochondria", Circulation 82: III-486 (1990) Abstract.
Crane et al., "Cardiac Retention of Tc-99m-Sestamibi is Related to Mitochondrial Viability", J. Nucl. Med. 32: 957 (1991).
Crane et al., "Effect of Mitochondrial Viability and Metabolism on Technetium-99m-Sestamibi Myocardial Retention", Eur. J. Nucl. Med. 20: 20-25 (1993).
Delmon-Moingeon, et al., "Uptake of the Cation Hexakis(2-methoxyisobutylisonitrile)-Technetium-99m by Human Carcinoma Cell Lines in Vitro", Cancer Research, 50: 2198-2202 (1990).
Duarte-Karim, "Affinity of Adriamycin to Phospholipids: A Possible Explanation for Cardiac Mitochondrial Lesions", Biochem. Biophys. Res. Commun., 71: 658-663 (1976).
Gosalvez et al, "Effects of Anticancer Agents on the Respiration of Isolated Mitochondria and Tumor Cells", Eur. J. Cancer, 10: 567-574 (1974).
Goodman and Hochstein, "Generation of Free Radicals and Lipid Peroxidation by Redox Cycling of Adriamycin and Daunomycin", Biochem. Biophys. Res. Commun., 77: 797-803 (1977).
Haugland, R. P., Handbook of Fluorescent Probes and Research Chemicals, (Molecular Probes, Inc.) 145-148 (1989).
March, ed., Advanced Organic Chemistry, 3rd ed., (John Wiley & Sons, Inc., NY, NY, 369-370, 429-430, 934, 1107-1108 (1985).
Mimnaugh et al, "The Effects of Adriamycin in Vitro and in Vivo on Hepatic Microsomal Drug-Metabolizing Enzymes: Role of Microsomal Lipid Peroxidation", Toxicol. Appl. Pharmacol., 61: 313-315 (1981).
Moore et al, "Inhibition of the Cardiac Mitochondrial Calcium Pump by Adriamycin in Vitro", Biochem. Med., 18: 131-138 (1977).
Nadakavukaren et al., "Increased Rhodamine 123 Uptake by Carcinoma Cells", Cancer Res., 45: 6093-6099 (1985).
Orlandi et al., "Doxorubicin Causes Release of Tc-99m-Sestamibi from Cardiac Mitochondria", JACC 19: 249A (1992).
Tritton, "Cell Surface Actions of Adriamycin", Pharmac. Ther. 49: 293-309 (1991).
Crane Paul D.
Orlandi Cesare
Boudreaux Gerald J.
The DuPont Merck Pharmaceutical Company
Vance David H.
Wong Leslie
LandOfFree
Method for detecting the cardiotoxicity of compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting the cardiotoxicity of compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting the cardiotoxicity of compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1601896